Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Polymorphic −844T/C inFasLPromoter Predicts Survival and Relapse in Non–Small Cell Lung Cancer

(2011) Wen-Wei Sung et al.   CLINICAL CANCER RESEARCH

Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival

(2011) Li Liu et al.   Journal of Thoracic Oncology

Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non–Small Cell Lung Cancer

(2010) Fan Li et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy

(2010) S Glaysher et al.   BRITISH JOURNAL OF CANCER

Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility

(2010) Jesús Lascorz et al.   CARCINOGENESIS

Predictive Effects of ERCC1 and XRCC3 SNP on Efficacy of Platinum-based Chemotherapy in Advanced NSCLC Patients

(2010) C. Zhou et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer

(2010) Gudrun Knechtel et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients

(2010) Sara S. Strom et al.   LEUKEMIA & LYMPHOMA

Pharmacogenetics and pharmacogenomics of anticancer agents

(2009) R. S. Huang et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia

(2009) D. H. Kim et al.   CLINICAL CANCER RESEARCH

Pharmacogenomics of platinum-based chemotherapy in NSCLC

(2009) Michelle AT Hildebrandt et al.   Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2009) Eray Goekkurt et al.   JOURNAL OF CLINICAL ONCOLOGY

APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells

(2009) Dong Wang et al.   LUNG CANCER

Regulation of damage recognition in mammalian global genomic nucleotide excision repair

(2009) Kaoru Sugasawa   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis

(2009) S. Garcia et al.   RHEUMATOLOGY

DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia

(2008) Bahadır Batar et al.   LEUKEMIA RESEARCH